A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...

MORE: Patients, health care providers face shortages of critical drugs, Senate report finds "All drug classes are vulnerable to shortage," Dr. Paul Abramowitz, CEO of ASHP, said in a statement.

TOPLINE: Drug classes such as alpha-1 blockers, atypical antipsychotics, and tricyclic antidepressants were associated with an increased incidence of intraoperative floppy iris syndrome (IFIS ...

Truvada and other forms of oral HIV tablets had the widest spending gap among the 10 drug classes; Minnesotans and their private insurers spent more than $13 million on that drug class in 2022 ...

A growing number of drugs are in short supply around the U.S., according to pharmacists. In the first three months of the year, there were 323 active medication shortages, surpassing the previous ...

Dermatology overtook anti-inflammatory as the largest specialty drug class by spend in 2024, rising to 27% of total specialty plan spend – up from 24.1% in 2023.

TG Therapeutics is pausing its cancer drug research and withdrawing the approved cancer drug Ukoniq from the market. The move comes as the FDA places greater scrutiny on Ukoniq’s drug class ...

So, we now have multiple new classes of drugs, multiple agents that are FDA-approved for the treatment of multiple myeloma, more than 15, 16 different drugs that have become available in that period.